title: Role of calcium-independent phospholipase A2 in complement-mediated glomerular epithelial cell injury.
abstract: In experimental membranous nephropathy, complement C5b-9-induced glomerular epithelial cell (GEC) injury leads to morphological changes in GEC and proteinuria, in association with phospholipase A(2) (PLA(2)) activation. The present study addresses the role of calcium-independent PLA(2) (iPLA(2)) in GEC injury. iPLA(2)beta short and iPLA(2)gamma were expressed in cultured rat GEC and normal rat glomeruli. To determine whether iPLA(2) is involved in complement-mediated arachidonic acid (AA) release, GEC were stably transfected with iPLA(2)gamma or iPLA(2)beta cDNAs (GEC-iPLA(2)gamma; GEC-iPLA(2)beta). Compared with control cells (GEC-Neo), GEC-iPLA(2)gamma and GEC-iPLA(2)beta demonstrated greater expression of iPLA(2) proteins and activities. Complement-mediated release of [(3)H]AA was augmented significantly in GEC-iPLA(2)gamma compared with GEC-Neo, and the augmented [(3)H]AA release was inhibited by the iPLA(2)-directed inhibitor bromoenol lactone (BEL). For comparison, overexpression of iPLA(2)gamma also amplified [(3)H]AA release after incubation of GEC with H(2)O(2), or chemical anoxia followed by reexposure to glucose (in vitro ischemia-reperfusion injury). In parallel with release of [(3)H]AA, complement-mediated production of prostaglandin E(2) was amplified in GEC-iPLA(2)gamma. Complement-mediated cytotoxicity was attenuated significantly in GEC-iPLA(2)gamma compared with GEC-Neo, and the cytoprotective effect of iPLA(2)gamma was reversed by BEL, and in part by indomethacin. Overexpression of iPLA(2)beta did not amplify complement-dependent [(3)H]AA release, but nonetheless attenuated complement-mediated cytotoxicity. Thus iPLA(2)gamma may be involved in complement-mediated release of AA. Expression of iPLA(2)gamma or iPLA(2)beta induces cytoprotection against complement-dependent GEC injury. Modulation of iPLA(2) activity may prove to be a novel approach to reducing GEC injury.
authors.affiliation: Department of Medicine, McGill University, Montreal, Quebec, Canada.
authors.forename: Daniel
authors.initials: D
authors.lastname: Cohen
authors.forename: Joan
authors.initials: J
authors.lastname: Papillon
authors.forename: Lamine
authors.initials: L
authors.lastname: Aoudjit
authors.forename: Hongping
authors.initials: H
authors.lastname: Li
authors.forename: Andrey V
authors.initials: AV
authors.lastname: Cybulsky
authors.forename: Tomoko
authors.initials: T
authors.lastname: Takano
mesh_terms: D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D015938:Complement Membrane Attack Complex / Q000633:toxicity; D015232:Dinoprostone / Q000378:metabolism; D004847:Epithelial Cells / Q000378:metabolism*; D015433:Glomerulonephritis, Membranous / Q000139:chemically induced / Q000201:enzymology*; D054522:Group VI Phospholipases A2 / Q000235:genetics / Q000378:metabolism*; D007527:Isoenzymes / Q000378:metabolism; D007678:Kidney Glomerulus / Q000378:metabolism*; D051381:Rats; D014162:Transfection; D014316:Tritium / Q000378:metabolism
chemical_list: D015938:Complement Membrane Attack Complex; D007527:Isoenzymes; D014316:Tritium; D016718:Arachidonic Acid; D054522:Group VI Phospholipases A2; D015232:Dinoprostone; D002118:Calcium